BMEA Biomea Fusion
- 5.640
- -0.170-2.93%
- 5.602
- -0.039-0.68%
Biomea Fusion News
Biomea Fusion, Inc. (BMEA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Biomea Fusion Stock Down 48% But Insiders Still In US$17k Profit
Biomea Fusion, Inc. (NASDAQ:BMEA) insiders who acquired shares over the previous 12 months, can probably afford to ignore the recent 48% decline in the stock price. After taking the recent loss into
Franco Valle Bought 42% More Shares In Biomea Fusion
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Signet Jewelers Limited (NYSE:SIG) fell sharply during Thursday's session following mixed first-quarter earnings including an 8.9% drop in same store sales.The company reported a first-quart
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLongeveron (NASDAQ:LGVN) stock increased by 74.6% to $3.16 during Thursday's regular session. The company's market cap stands at $20.0 million. BioRestorative Therapies (NASDAQ:BRTX) stock rose
Biomea Fusion(BMEA.US) Officer Buys US$55,361.08 in Common Stock
$Biomea Fusion(BMEA.US)$ Officer Valle Franco purchased 12,509 shares of common stock on Jun 11, 2024 at an average price of $4.4257 for a total value of $55,361.08.Source: Announcement What is statem
Truist Cuts Biomea Fusion to Hold, Cites Clinical Hold Uncertainty
This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Truist Financial Maintains Biomea Fusion(BMEA.US) With Hold Rating, Maintains Target Price $5
Truist Financial analyst Srikripa Devarakonda maintains $Biomea Fusion(BMEA.US)$ with a hold rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of
Truist Financial Initiates Biomea Fusion(BMEA.US) With Hold Rating, Announces Target Price $5
Truist Financial analyst Srikripa Devarakonda initiates coverage on $Biomea Fusion(BMEA.US)$ with a hold rating, and sets the target price at $5.According to TipRanks data, the analyst has a success r
Biomea Fusion Downgraded to Hold at Truist Securities With No Price Target Following Clinical Hold Placed by FDA Last Week
05:08 AM EDT, 06/11/2024 (MT Newswires) -- Biomea Fusion Downgraded to Hold at Truist Securities With No Price Target Following Clinical Hold Placed by FDA Last Week Price: 4.2800, Change: -0.03, Perc
Express News | Biomea Fusion Shares Down 1.9% Premarket After Truist Securities Cuts to Hold From Buy
Express News | Biomea Fusion Inc : Truist Securities Cuts to Hold From Buy
Sector Update: Health Care Stocks Higher Late Afternoon
Health care stocks rose late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding about 0.2%. The iShares Biotechnology ETF (IBB) fell 0.5%.
Top Midday Decliners
Biomea Fusion (BMEA) shares plummeted 64% in intraday trading after the company said the US Food and Drug Administration placed a full clinical hold on early trials of its investigational covalent men
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results before schedule and filed to sell up to 75 million shares.
Why Biomea Fusion (BMEA) Stock Is Down 60%
Biomea Fusion Inc (NASDAQ:BMEA) shares are trading lower by 62.7% to $4.20 during Friday's session after the company received notice from the FDA that Its trials of BMF-219 have been placed on clinica
Biomea Fusion Price Target Cut to $10.00/Share From $45.00 by Piper Sandler
Biomea Fusion Price Target Cut to $10.00/Share From $45.00 by Piper Sandler
Express News | Piper Sandler Maintains Overweight on Biomea Fusion, Lowers Price Target to $10
Biomea Fusion Cut to Equal-Weight From Overweight by Barclays
Biomea Fusion Cut to Equal-Weight From Overweight by Barclays
Analysis
Price Target
No Data
